Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Other Non Operating Income (2016 - 2022)

Edesa Biotech's Other Non Operating Income history spans 10 years, with the latest figure at -$13737.0 for Q3 2022.

  • For Q3 2022, Other Non Operating Income rose 80.92% year-over-year to -$13737.0; the TTM value through Sep 2022 reached -$21114.0, down 62.14%, while the annual FY2024 figure was -$21042.0, 3.22% up from the prior year.
  • Other Non Operating Income for Q3 2022 was -$13737.0 at Edesa Biotech, down from -$7013.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $153890.0 in Q3 2020 and bottomed at -$71985.0 in Q3 2021.
  • The 5-year median for Other Non Operating Income is -$2687.0 (2019), against an average of $7870.2.
  • The largest annual shift saw Other Non Operating Income surged 237.66% in 2018 before it tumbled 1110.57% in 2020.
  • A 5-year view of Other Non Operating Income shows it stood at $24681.0 in 2018, then plummeted by 108.28% to -$2043.0 in 2019, then crashed by 1110.57% to -$24732.0 in 2020, then skyrocketed by 86.53% to -$3331.0 in 2021, then crashed by 312.4% to -$13737.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Other Non Operating Income are -$13737.0 (Q3 2022), -$7013.0 (Q2 2022), and $2967.0 (Q1 2022).